Newsroom
January 19, 2021
An article published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association cites decades of published scientific evidence to make a compelling case for SARS-CoV-2’s expected long-term effects on the brain and nervous system.
January 19, 2021
Dr. Barbara Taylor, Infectious Diseases, was highlighted as the principal investigator of the local study site for the Novavax COVID-19 vaccine trial, part of the COVID-19 Prevention Network, in Yahoo! Finance. Read here.
January 19, 2021
Dr. Barbara Taylor, Infectious Diseases, was highlighted as the principal investigator of the local study site for the Novavax COVID-19 vaccine trial, part of the COVID-19 Prevention Network, in the San Francisco Chronicle. Read here.
January 19, 2021
Dr. Gabriel de Erausquin and Dr. Sudha Seshadri, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and their work on the long-term effects of COVID-19 on the brain, are featured in this column by the Alzheimer’s Association – Texas, appearing in several publications around the state. Read the story.
January 19, 2021
Dr. Thomas Patterson, Infectious Diseases, was interviewed by News 4 San Antonio about the drug combo, that includes baricitinib, which is helping COVID patients recover quicker. Read and watch the story.
January 19, 2021
Dr. Gabriel de Erausquin, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, interviewed by NPR Science Correspondent Jon Hamilton, is mentioned in this story about how COVID-19 affects the brain. Listen here.